$USPH
U S PHYSICAL THERAPY INC /NV

2024 Q1 Form 10-K Financial Statement

#000114036124010454 Filed on February 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $155.7M $154.8M $604.8M
YoY Change 4.83% 9.65% 9.34%
Cost Of Revenue $127.3M $124.3M $483.3M
YoY Change 8.18% 9.65% 9.56%
Gross Profit $28.40M $30.52M $121.5M
YoY Change -7.96% 9.65% 8.47%
Gross Profit Margin 18.24% 19.71% 20.09%
Selling, General & Admin $14.09M $13.90M $51.95M
YoY Change 1.63% 16.57% 12.67%
% of Gross Profit 49.59% 45.55% 42.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.095M $4.113M $15.70M
YoY Change 8.1% 8.44% 6.46%
% of Gross Profit 14.42% 13.48% 12.92%
Operating Expenses $14.09M $13.90M $51.95M
YoY Change 1.63% 16.57% 12.67%
Operating Profit $14.32M $16.61M $52.06M
YoY Change -15.78% 4.46% -8.34%
Interest Expense -$92.00K -$193.0K -$4.184M
YoY Change -95.86% -90.24% 11.72%
% of Operating Profit -0.64% -1.16% -8.04%
Other Income/Expense, Net $440.0K $1.179M -$2.685M
YoY Change -116.91% -560.55% 118.29%
Pretax Income $14.76M $106.0K $49.38M
YoY Change 2.5% -97.68% -11.15%
Income Tax $3.139M $1.399M $12.16M
% Of Pretax Income 21.27% 1319.81% 24.62%
Net Earnings $8.046M -$5.729M $28.24M
YoY Change 8.58% 3851.03% -12.19%
Net Earnings / Revenue 5.17% -3.7% 4.67%
Basic Earnings Per Share $0.46 $1.28
Diluted Earnings Per Share $0.46 -$0.38 $1.28
COMMON SHARES
Basic Shares Outstanding 15.07M 14.99M 14.19M
Diluted Shares Outstanding 15.02M 14.19M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $132.3M $152.8M $152.8M
YoY Change 305.74% 383.72% 383.72%
Cash & Equivalents $132.3M $152.8M $152.8M
Short-Term Investments
Other Short-Term Assets $11.72M $10.83M $8.730M
YoY Change 9.22% -2.14% -15.79%
Inventory
Prepaid Expenses
Receivables $55.36M $51.87M $69.72M
Other Receivables $0.00 $0.00 $2.100M
Total Short-Term Assets $221.1M $233.4M $233.4M
YoY Change 87.74% 109.75% 109.75%
LONG-TERM ASSETS
Property, Plant & Equipment $26.25M $26.10M $129.5M
YoY Change 6.55% 5.47% 1.39%
Goodwill $534.3M $509.6M
YoY Change 6.57% 3.13%
Intangibles $116.9M $109.7M
YoY Change 7.25% 0.85%
Long-Term Investments $12.16M $12.26M $12.26M
YoY Change 0.0% 1.03% 1.03%
Other Assets $4.431M $2.821M $2.821M
YoY Change 70.88% -32.01% -32.01%
Total Long-Term Assets $796.1M $763.9M $763.9M
YoY Change 6.1% 2.27% 2.27%
TOTAL ASSETS
Total Short-Term Assets $221.1M $233.4M $233.4M
Total Long-Term Assets $796.1M $763.9M $763.9M
Total Assets $1.017B $997.2M $997.2M
YoY Change 17.18% 16.21% 16.21%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.866M $3.898M $3.898M
YoY Change 14.95% -40.07% -40.07%
Accrued Expenses $53.75M $55.34M $77.31M
YoY Change 18.86% 47.93% 8.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.222M $7.691M $7.691M
YoY Change 19.3% -2.19% -2.19%
Total Short-Term Liabilities $102.5M $102.2M $102.2M
YoY Change 12.88% 19.53% 19.53%
LONG-TERM LIABILITIES
Long-Term Debt $136.7M $139.0M $139.0M
YoY Change -25.14% -20.95% -20.95%
Other Long-Term Liabilities $2.988M $2.356M $79.01M
YoY Change -78.46% -81.92% -13.14%
Total Long-Term Liabilities $139.7M $141.3M $218.0M
YoY Change -28.91% -25.16% -18.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $102.5M $102.2M $102.2M
Total Long-Term Liabilities $139.7M $141.3M $218.0M
Total Liabilities $345.3M $345.0M $521.0M
YoY Change -10.17% -7.65% -3.93%
SHAREHOLDERS EQUITY
Retained Earnings $223.6M $223.8M
YoY Change -4.77% -3.94%
Common Stock $172.0K $172.0K
YoY Change 13.16% 13.16%
Preferred Stock
YoY Change
Treasury Stock (at cost) $31.63M $31.63M
YoY Change 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity $479.8M $476.2M $476.2M
YoY Change
Total Liabilities & Shareholders Equity $1.017B $997.2M $997.2M
YoY Change 17.18% 16.21% 16.21%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $8.046M -$5.729M $28.24M
YoY Change 8.58% 3851.03% -12.19%
Depreciation, Depletion And Amortization $4.095M $4.113M $15.70M
YoY Change 8.1% 8.44% 6.46%
Cash From Operating Activities $4.419M $26.83M $81.98M
YoY Change -61.06% 55.12% 40.04%
INVESTING ACTIVITIES
Capital Expenditures $1.838M $2.220M $9.294M
YoY Change -10.73% 131.73% 12.68%
Acquisitions $15.97M $26.58M
YoY Change 175.55% -55.54%
Other Investing Activities -$88.00K -$6.194M -$321.0K
YoY Change -99.17% -85.4% -99.56%
Cash From Investing Activities -$20.46M -$8.414M -$45.02M
YoY Change 61.38% -80.61% -44.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $163.6M
YoY Change
Debt Paid & Issued, Net $938.0K $3.750M
YoY Change 0.0% 100.0%
Cash From Financing Activities -4.490M -13.28M 84.27M
YoY Change -291.63% -167.17% 227.14%
NET CHANGE
Cash From Operating Activities 4.419M 26.83M 81.98M
Cash From Investing Activities -20.46M -8.414M -45.02M
Cash From Financing Activities -4.490M -13.28M 84.27M
Net Change In Cash -20.54M 5.140M 121.2M
YoY Change -2131.16% -181.33% 3904.99%
FREE CASH FLOW
Cash From Operating Activities $4.419M $26.83M $81.98M
Capital Expenditures $1.838M $2.220M $9.294M
Free Cash Flow $2.581M $24.61M $72.68M
YoY Change -72.22% 50.63% 44.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31594000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2736000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2829000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51866000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51934000
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
17854000
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
16671000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
10830000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
11067000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
233375000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
111266000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
63982000
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
62074000
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
46941000
CY2022Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
42877000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110923000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
104951000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
84821000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80203000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26102000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24748000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
103431000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
103004000
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12256000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
12131000
CY2023Q4 us-gaap Goodwill
Goodwill
509571000
CY2022Q4 us-gaap Goodwill
Goodwill
494101000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
109682000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
108755000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2821000
CY2023Q4 us-gaap Assets
Assets
997238000
CY2022Q4 us-gaap Assets
Assets
858154000
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3898000
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3300000
CY2023Q4 usph Accounts Payable Due To Seller Of Acquired Business
AccountsPayableDueToSellerOfAcquiredBusiness
0
CY2022Q4 usph Accounts Payable Due To Seller Of Acquired Business
AccountsPayableDueToSellerOfAcquiredBusiness
3204000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55344000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37413000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35252000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33709000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7691000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7863000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
102185000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
85489000
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1289000
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1913000
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
31000000
CY2022Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
142918000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
21303000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
76653000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77934000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2356000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13029000
CY2023Q4 us-gaap Liabilities
Liabilities
345000000
CY2022Q4 us-gaap Liabilities
Liabilities
373586000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
174828000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
167515000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17202291
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
152000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281096000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110317000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2782000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4004000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
223772000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
232948000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31628000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
476194000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
315793000
CY2023Q4 us-gaap Minority Interest
MinorityInterest
1216000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
1260000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
477410000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317053000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
997238000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
858154000
CY2022 us-gaap Profit Loss
ProfitLoss
43407000
CY2021 us-gaap Profit Loss
ProfitLoss
57924000
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
1642000
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-5378000
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
0
CY2023 usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-420000
CY2022 usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
1374000
CY2021 usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
0
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
35998000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
47411000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8981000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
11249000
CY2021 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
17093000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27017000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36162000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
40831000
CY2022 us-gaap Profit Loss
ProfitLoss
43407000
CY2021 us-gaap Profit Loss
ProfitLoss
57924000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15695000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14743000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11591000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6172000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5548000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
7236000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
7264000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7867000
CY2023 usph Gain Loss On Revaluation Of Put Right Liability
GainLossOnRevaluationOfPutRightLiability
2582000
CY2022 usph Gain Loss On Revaluation Of Put Right Liability
GainLossOnRevaluationOfPutRightLiability
-5000
CY2021 usph Gain Loss On Revaluation Of Put Right Liability
GainLossOnRevaluationOfPutRightLiability
0
CY2022 usph Change In Fair Value Of Contingent Consideration Liability
ChangeInFairValueOfContingentConsiderationLiability
2520000
CY2021 usph Change In Fair Value Of Contingent Consideration Liability
ChangeInFairValueOfContingentConsiderationLiability
0
CY2023 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-166000
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
643000
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
0
CY2022 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-83000
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-134000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5645000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10279000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9417000
CY2023 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
356000
CY2022 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
307000
CY2021 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
1538000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
197000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
5940000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
633000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7755000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4657000
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1254000
CY2022 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2546000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4848000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81978000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76406000
CY2023 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
9294000
CY2022 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8248000
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
8201000
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
26582000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
59788000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
86823000
CY2023 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
10986000
CY2022 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
14987000
CY2021 usph Payments To Acquire Redeemable Non Controlling Interest
PaymentsToAcquireRedeemableNonControllingInterest
28465000
CY2023 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
281000
CY2022 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
280000
CY2021 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
1274000
CY2023 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
875000
CY2022 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
402000
CY2021 us-gaap Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates
ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates
69000
CY2023 usph Distributions From Unconsolidated Affiliate
DistributionsFromUnconsolidatedAffiliate
830000
CY2022 usph Distributions From Unconsolidated Affiliate
DistributionsFromUnconsolidatedAffiliate
1259000
CY2021 usph Distributions From Unconsolidated Affiliate
DistributionsFromUnconsolidatedAffiliate
152000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81269000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-124136000
CY2023 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
16100000
CY2022 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
15348000
CY2021 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
16931000
CY2023 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
24128000
CY2022 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21321000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18765000
CY2023 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
55000000
CY2022 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
184000000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
218000000
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
930000
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4899000
CY2023 usph Payment Of Medicare Accelerated And Advance Funds
PaymentOfMedicareAcceleratedAndAdvanceFunds
0
CY2022 usph Payment Of Medicare Accelerated And Advance Funds
PaymentOfMedicareAcceleratedAndAdvanceFunds
0
CY2021 usph Payment Of Medicare Accelerated And Advance Funds
PaymentOfMedicareAcceleratedAndAdvanceFunds
14054000
CY2023 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
CY2022 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
12000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
28000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84268000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25759000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
43379000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
121231000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3027000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4351000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31594000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28567000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32918000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152825000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31594000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28567000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4926000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7615000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12214000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
8655000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
5687000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
1352000
CY2023 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
1815000
CY2022 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
1574000
CY2021 usph Purchase Of Business Seller Financing Portion
PurchaseOfBusinessSellerFinancingPortion
3050000
CY2023Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
1087000
CY2022Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
1074000
CY2021Q4 usph Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity
NotesPayableRelatedToPurchaseOfRedeemableNonControllingInterestTemporaryEquity
1759000
CY2023Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
200000
CY2022Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
296000
CY2021Q4 usph Notes Payable Related To Purchase Of Non Controlling Interest Permanent Equity
NotesPayableRelatedToPurchaseOfNonControllingInterestPermanentEquity
0
CY2023 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4136000
CY2022 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1580000
CY2021 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
914000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">In preparing the Company’s consolidated financial statements, management makes certain estimates and assumptions, especially in relation to, but not limited to, goodwill impairment, tradenames, allocations of purchase price, allowance for receivables, tax provision and contractual allowances, that affect the amounts reported in the consolidated financial statements and related disclosures. Actual results may differ from these estimates.</div>
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Registrant Name
EntityRegistrantName
U S PHYSICAL THERAPY INC /NV
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0000885978
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Auditor Firm
AuditorFirmId
248
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
1-11151
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
76-0364866
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
1300 WEST SAM HOUSTON PARKWAY SOUTH
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 300
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
HOUSTON
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77042
CY2023 dei City Area Code
CityAreaCode
713
CY2023 dei Local Phone Number
LocalPhoneNumber
297-7000
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
CY2023 dei Trading Symbol
TradingSymbol
USPH
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1100000000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
15068426
CY2023 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152825000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4149000
CY2023Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
137702000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24815000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15216326
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
172000
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2214737
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
2214737
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
604802000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
553144000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
495022000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
353390000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
319191000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
278469000
CY2023 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
123731000
CY2022 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
116381000
CY2021 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
94066000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6172000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5548000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5305000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
483293000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
441120000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
377840000
CY2023 us-gaap Gross Profit
GrossProfit
121509000
CY2022 us-gaap Gross Profit
GrossProfit
112024000
CY2021 us-gaap Gross Profit
GrossProfit
117182000
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51953000
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46111000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46533000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
17495000
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9112000
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
52061000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
56801000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
70649000
CY2023 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
9303000
CY2022 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
5779000
CY2021 usph Interest Expense Debt And Other
InterestExpenseDebtAndOther
942000
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
3774000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2023 usph Change In Fair Value Of Contingent Consideration Liability
ChangeInFairValueOfContingentConsiderationLiability
-1550000
CY2022 usph Change In Fair Value Of Contingent Consideration Liability
ChangeInFairValueOfContingentConsiderationLiability
2520000
CY2021 usph Change In Fair Value Of Contingent Consideration Liability
ChangeInFairValueOfContingentConsiderationLiability
0
CY2023 usph Gain Loss On Revaluation Of Put Right Liability
GainLossOnRevaluationOfPutRightLiability
2582000
CY2022 usph Gain Loss On Revaluation Of Put Right Liability
GainLossOnRevaluationOfPutRightLiability
-5000
CY2021 usph Gain Loss On Revaluation Of Put Right Liability
GainLossOnRevaluationOfPutRightLiability
0
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
955000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1175000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
112000
CY2023 usph Relief Funds
ReliefFunds
467000
CY2022 usph Relief Funds
ReliefFunds
0
CY2021 usph Relief Funds
ReliefFunds
4597000
CY2023 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
CY2022 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0
CY2021 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
2635000
CY2023 usph Resolution Of Payor Matter
ResolutionOfPayorMatter
0
CY2022 usph Resolution Of Payor Matter
ResolutionOfPayorMatter
0
CY2021 usph Resolution Of Payor Matter
ResolutionOfPayorMatter
1216000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
390000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
859000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
199000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2685000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1230000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2547000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49376000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
55571000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
73196000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12156000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12164000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15272000
CY2023 us-gaap Profit Loss
ProfitLoss
37220000
CY2022 us-gaap Profit Loss
ProfitLoss
43407000
CY2021 us-gaap Profit Loss
ProfitLoss
57924000
CY2023 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
4426000
CY2022 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
6902000
CY2021 usph Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity
NetIncomeLossAttributableToRedeemableNoncontrollingInterestTemporaryEquity
11358000
CY2023 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
4555000
CY2022 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
4347000
CY2021 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
5735000
CY2023 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8981000
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
11249000
CY2021 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17093000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
28239000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
32158000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
40831000
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.25
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.25
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.41
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.41
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14188000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14188000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12985000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12985000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12898000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12898000
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.72
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.64
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.46
CY2023 us-gaap Profit Loss
ProfitLoss
37220000
CY2021 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
57924000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
277630000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
40831000
CY2021 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
5735000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2021 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
9686000
CY2021 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
978000
CY2021 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
98000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7867000
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
18765000
CY2021 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5572000
CY2021 usph Short Swing Profit Settlement
ShortSwingProfitSettlement
20000
CY2021 us-gaap Stockholders Equity Other
StockholdersEquityOther
1000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
297181000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
297181000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
32158000
CY2022 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
4347000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000
CY2022 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
2896000
CY2022 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
454000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7264000
CY2022 usph Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans
TransferOfCompensationLiabilityForCertainStockIssuedPursuantToIncentivePlans
707000
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
21321000
CY2022 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5246000
CY2022 usph Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity
DeferredTaxesRelatedToRedeemableNonControllingInterestTemporaryEquity
613000
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4004000
CY2022 us-gaap Stockholders Equity Other
StockholdersEquityOther
695000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317053000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
317053000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
28239000
CY2023 usph Net Income Loss Attributable To Noncontrolling Interest Permanent Equity
NetIncomeLossAttributableToNoncontrollingInterestPermanentEquity
4555000
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
163646000
CY2023 usph Revaluation Of Redeemable Non Controlling Interest Net Of Tax
RevaluationOfRedeemableNonControllingInterestNetOfTax
13564000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7236000
CY2023 usph Sale Of Non Controlling Interest Net Of Tax And Purchases
SaleOfNonControllingInterestNetOfTaxAndPurchases
4000
CY2023 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
119000
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
24128000
CY2023 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4567000
CY2023 usph Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity
DeferredTaxesRelatedToRedeemableNonControllingInterestTemporaryEquity
587000
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1224000
CY2023 us-gaap Stockholders Equity Other
StockholdersEquityOther
-308000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
477410000
CY2023 us-gaap Profit Loss
ProfitLoss
37220000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5305000
CY2023 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
420000
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
305000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
56000
CY2023 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
4490000
CY2022 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
4309000
CY2021 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
5688000
CY2023 usph Change In Fair Value Of Contingent Consideration Liability
ChangeInFairValueOfContingentConsiderationLiability
-1550000
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
955000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1175000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
112000
CY2023 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
17495000
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
9112000
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58537000
CY2023 usph Proceeds From Sales Of Non Controlling Interest Permanent
ProceedsFromSalesOfNonControllingInterestPermanent
102000
CY2022 usph Proceeds From Sales Of Non Controlling Interest Permanent
ProceedsFromSalesOfNonControllingInterestPermanent
0
CY2021 usph Proceeds From Sales Of Non Controlling Interest Permanent
ProceedsFromSalesOfNonControllingInterestPermanent
131000
CY2023 us-gaap Payments For Proceeds From Limited Partnership
PaymentsForProceedsFromLimitedPartnership
0
CY2022 us-gaap Payments For Proceeds From Limited Partnership
PaymentsForProceedsFromLimitedPartnership
-373000
CY2021 us-gaap Payments For Proceeds From Limited Partnership
PaymentsForProceedsFromLimitedPartnership
-275000
CY2023 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-321000
CY2022 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
CY2021 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45015000
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163646000
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
24000000
CY2022 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
101000000
CY2021 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
316000000
CY2023 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
4400000
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3750000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1875000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
150000000
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
CY2023 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1779000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
CY2023 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
524000
CY2022 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0
CY2021 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0
CY2023 usph Notes Receivable Related To Sale Of Non Controlling Interest Permanent Equity
NotesReceivableRelatedToSaleOfNonControllingInterestPermanentEquity
458000
CY2022 usph Notes Receivable Related To Sale Of Non Controlling Interest Permanent Equity
NotesReceivableRelatedToSaleOfNonControllingInterestPermanentEquity
0
CY2021 usph Notes Receivable Related To Sale Of Non Controlling Interest Permanent Equity
NotesReceivableRelatedToSaleOfNonControllingInterestPermanentEquity
0
CY2023 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1916667
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
90
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163600000
CY2023Q2 usph Underwriting Discount
UnderwritingDiscount
8600000
CY2023Q2 usph Stock Issuance Expense
StockIssuanceExpense
200000
CY2023Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35000000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023 usph Number Of Regions
NumberOfRegions
6
CY2022 usph Number Of Regions
NumberOfRegions
6
CY2023 usph Number Of Regions
NumberOfRegions
6
CY2023 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2600000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3600000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1000000
CY2023 usph Gain Loss On Revaluation Of Put Right Liability
GainLossOnRevaluationOfPutRightLiability
2600000
CY2023Q4 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
3700000
CY2023 us-gaap Unrealized Gain Loss On Interest Rate Cash Flow Hedges Pretax Accumulated Other Comprehensive Income Loss
UnrealizedGainLossOnInterestRateCashFlowHedgesPretaxAccumulatedOtherComprehensiveIncomeLoss
-1200000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
9800000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
8300000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2023 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"> <span style="font-style: normal;">Reclassification of Prior Period Presentation</span><br/> </div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"><span style="font-style: normal;"> <br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;"><span style="font-style: normal;"> <span style="font-weight: normal;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span><br/> </span></div>
CY2023 us-gaap Net Income Loss
NetIncomeLoss
28239000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
32158000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
40831000
CY2023 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-13565000
CY2022 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-3890000
CY2021 usph Charges To Retained Earnings Revaluation Of Non Controlling Interests
ChargesToRetainedEarningsRevaluationOfNonControllingInterests
-13011000
CY2023 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-3466000
CY2022 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-994000
CY2021 usph Income Tax Reconciliation Income Tax Expense Benefit At Federal And State Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-3324000
CY2023 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
18140000
CY2022 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
29262000
CY2021 usph Income Loss From Operations After Revaluation Of Non Controlling Interests
IncomeLossFromOperationsAfterRevaluationOfNonControllingInterests
31144000
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.28
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.28
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.25
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.25
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.41
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.41
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14188000
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14188000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12985000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12985000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12898000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12898000
CY2023 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
3
CY2023 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
500000
CY2023 usph Number Of Partnerships In Which The Company Sold Interests
NumberOfPartnershipsInWhichTheCompanySoldInterests
4
CY2023 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
600000
CY2022 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
3
CY2022 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
300000
CY2021 usph Number Of Partnership In Which Interest Acquired
NumberOfPartnershipInWhichInterestAcquired
5
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
1300000
CY2021 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Sale Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent
100000
CY2022Q4 us-gaap Goodwill
Goodwill
494101000
CY2021Q4 us-gaap Goodwill
Goodwill
434679000
CY2023 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
28083000
CY2022 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
72674000
CY2023 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
3187000
CY2022 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-4140000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
15800000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9112000
CY2023Q4 us-gaap Goodwill
Goodwill
509571000
CY2022Q4 us-gaap Goodwill
Goodwill
494101000
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
15800000
CY2022 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9100000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
147690000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38008000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
109682000
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
139490000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
30735000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
108755000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7273000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6523000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3698000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25641000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22912000
CY2023Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
8847000
CY2022Q4 usph Patients And Payors Related Liability
PatientsAndPayorsRelatedLiability
8094000
CY2023Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
2301000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1666000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1006000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12285000
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
620000
CY2023Q4 usph Other Property Taxes Payable
OtherPropertyTaxesPayable
355000
CY2022Q4 usph Other Property Taxes Payable
OtherPropertyTaxesPayable
277000
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
235000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
273000
CY2023Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
231000
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
243000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4443000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3328000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
55344000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
37413000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
148150000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1468000
CY2023Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
146682000
CY2022Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
185555000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1861000
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
183694000
CY2023Q4 usph Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
8111000
CY2023Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
420000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7691000
CY2022Q4 usph Debt Instrument Face Amount Current
DebtInstrumentFaceAmountCurrent
8271000
CY2022Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
408000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7863000
CY2023Q4 usph Debt Instrument Face Amount Noncurrent
DebtInstrumentFaceAmountNoncurrent
140039000
CY2023Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1048000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
138991000
CY2022Q4 usph Debt Instrument Face Amount Noncurrent
DebtInstrumentFaceAmountNoncurrent
177284000
CY2022Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1453000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
175831000
CY2023 us-gaap Profit Loss
ProfitLoss
37220000
CY2022 us-gaap Profit Loss
ProfitLoss
43407000
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
1642000
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-5378000
CY2023 usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
-420000
CY2022 usph Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate
OtherComprehensiveIncomeLossTaxExpenseBenefitAtFederalAndStateStatutoryIncomeTaxRate
1374000
CY2023 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
35998000
CY2022 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
47411000
CY2023 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8981000
CY2022 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
11249000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27017000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36162000
CY2023Q4 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
3736000
CY2022Q4 us-gaap Interest Rate Cash Flow Hedge Asset At Fair Value
InterestRateCashFlowHedgeAssetAtFairValue
5378000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
38559000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
35154000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
32021000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1353000
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1049000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1160000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
8912000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
6287000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
7057000
CY2023 us-gaap Lease Cost
LeaseCost
48824000
CY2022 us-gaap Lease Cost
LeaseCost
42490000
CY2021 us-gaap Lease Cost
LeaseCost
40238000
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
39813000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
36136000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
33192000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
36264000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
40502000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
46088000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
38809000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
30628000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
22845000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
15275000
CY2023Q4 usph Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
13174000
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
120731000
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8826000
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
111905000
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M24D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.04
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.029
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.028
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1680000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1464000
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
574000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
605000
CY2023Q4 usph Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
28592000
CY2022Q4 usph Deferred Tax Assets Lease Obligations
DeferredTaxAssetsLeaseObligations
28525000
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30846000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30594000
CY2023Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
27290000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
23836000
CY2023Q4 usph Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
26427000
CY2022Q4 usph Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
26318000
CY2023Q4 usph Deferred Tax Liabilities Gain On Cash Flow Hedge
DeferredTaxLiabilitiesGainOnCashFlowHedge
955000
CY2022Q4 usph Deferred Tax Liabilities Gain On Cash Flow Hedge
DeferredTaxLiabilitiesGainOnCashFlowHedge
1373000
CY2023Q4 usph Deferred Tax Liabilities Change In Revaluation Of Put Right Liability
DeferredTaxLiabilitiesChangeInRevaluationOfPutRightLiability
586000
CY2022Q4 usph Deferred Tax Liabilities Change In Revaluation Of Put Right Liability
DeferredTaxLiabilitiesChangeInRevaluationOfPutRightLiability
0
CY2023Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
403000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
370000
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
55661000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
51897000
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
24815000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
21303000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
8483000
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
9307000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
11782000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2135000
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.053
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2079000
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.047
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2478000
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.044
CY2023 usph Effective Income Tax Rate Reconciliation Shortfall Excess Equity Compensation Deduction Amount
EffectiveIncomeTaxRateReconciliationShortfallExcessEquityCompensationDeductionAmount
-123000
CY2023 usph Effective Income Tax Rate Reconciliation Shortfall Excess Equity Compensation Deduction
EffectiveIncomeTaxRateReconciliationShortfallExcessEquityCompensationDeduction
-0.003
CY2022 usph Effective Income Tax Rate Reconciliation Shortfall Excess Equity Compensation Deduction Amount
EffectiveIncomeTaxRateReconciliationShortfallExcessEquityCompensationDeductionAmount
-149000
CY2022 usph Effective Income Tax Rate Reconciliation Shortfall Excess Equity Compensation Deduction
EffectiveIncomeTaxRateReconciliationShortfallExcessEquityCompensationDeduction
-0.003
CY2021 usph Effective Income Tax Rate Reconciliation Shortfall Excess Equity Compensation Deduction Amount
EffectiveIncomeTaxRateReconciliationShortfallExcessEquityCompensationDeductionAmount
246000
CY2021 usph Effective Income Tax Rate Reconciliation Shortfall Excess Equity Compensation Deduction
EffectiveIncomeTaxRateReconciliationShortfallExcessEquityCompensationDeduction
0.004
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
710000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.018
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
629000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.014
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1258000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.022
CY2023 usph Effective Income Tax Rate Reconciliation Return To Provision Adjustments Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsAmount
705000
CY2023 usph Effective Income Tax Rate Reconciliation Return To Provision Adjustments
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments
0.017
CY2022 usph Effective Income Tax Rate Reconciliation Return To Provision Adjustments Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsAmount
0
CY2022 usph Effective Income Tax Rate Reconciliation Return To Provision Adjustments
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments
0
CY2021 usph Effective Income Tax Rate Reconciliation Return To Provision Adjustments Amount
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustmentsAmount
0
CY2021 usph Effective Income Tax Rate Reconciliation Return To Provision Adjustments
EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments
0
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12156000
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.301
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12164000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.274
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15272000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.272
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6996000
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-770000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7477000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
512000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
518000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2107000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
7508000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-252000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
9584000
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3819000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
9933000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
4866000
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
829000
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
9800000
CY2023 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y9M
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
2483000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
822000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4648000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12416000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5688000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12156000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12164000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15272000
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
1000000
CY2022 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2021 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Expense
UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
0
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023 usph Percentage Of General Partnership Interest Owned
PercentageOfGeneralPartnershipInterestOwned
0.01
CY2023 us-gaap Revenues
Revenues
604802000
CY2022 us-gaap Revenues
Revenues
553144000
CY2021 us-gaap Revenues
Revenues
495022000
CY2023 us-gaap Labor And Related Expense
LaborAndRelatedExpense
353390000
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
319191000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
278469000
CY2023 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
123731000
CY2022 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
116381000
CY2021 usph Rent Supplies Contract Labor And Other
RentSuppliesContractLaborAndOther
94066000
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
6172000
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5548000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5305000
CY2023 us-gaap Costs And Expenses
CostsAndExpenses
483293000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
441120000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
377840000
CY2023 us-gaap Gross Profit
GrossProfit
121509000
CY2022 us-gaap Gross Profit
GrossProfit
112024000
CY2021 us-gaap Gross Profit
GrossProfit
117182000
CY2023Q4 us-gaap Assets
Assets
997238000
CY2022Q4 us-gaap Assets
Assets
858154000
CY2021Q4 us-gaap Assets
Assets
749426000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7200000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7300000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7800000
CY2023Q4 usph Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed
ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
124638
CY2022Q4 usph Share Based Compensation Arrangement By Share Based Payment Award For Shares Outstanding Restrictions Had Not Lapsed
ShareBasedCompensationArrangementByShareBasedPaymentAwardForSharesOutstandingRestrictionsHadNotLapsed
124939
CY2009Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
859499
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0
CY2023Q2 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1916667
CY2023Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
90
CY2023Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
163600000
CY2023Q2 usph Underwriting Discount
UnderwritingDiscount
8600000
CY2023Q2 usph Stock Issuance Expense
StockIssuanceExpense
200000
CY2023Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
35000000
CY2023 usph Defined Contribution Plan Period For New Employees Covered Under Plan
DefinedContributionPlanPeriodForNewEmployeesCoveredUnderPlan
P3M
CY2023 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2023 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
2200000
CY2022 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
2000000
CY2021 usph Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
1900000
CY2022Q1 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
2800000
CY2021 usph Short Swing Profit Settlement
ShortSwingProfitSettlement
20000
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001140361-24-010454-index-headers.html Edgar Link pending
0001140361-24-010454-index.html Edgar Link pending
0001140361-24-010454.txt Edgar Link pending
0001140361-24-010454-xbrl.zip Edgar Link pending
ef20015310_10k.htm Edgar Link pending
ef20015310_ex21-1.htm Edgar Link pending
ef20015310_ex23-1.htm Edgar Link pending
ef20015310_ex31-1.htm Edgar Link pending
ef20015310_ex31-2.htm Edgar Link pending
ef20015310_ex32-1.htm Edgar Link pending
ef20015310_ex4-1.htm Edgar Link pending
ef20015310_ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
ef20015310_10k_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usph-20231231.xsd Edgar Link pending
usph-20231231_cal.xml Edgar Link unprocessable
usph-20231231_def.xml Edgar Link unprocessable
usph-20231231_lab.xml Edgar Link unprocessable
usph-20231231_pre.xml Edgar Link unprocessable